[HTML][HTML] Covid-19 in immune-mediated inflammatory diseases—case series from New York
R Haberman, J Axelrad, A Chen… - … England Journal of …, 2020 - Mass Medical Soc
R Haberman, J Axelrad, A Chen, R Castillo, D Yan, P Izmirly, A Neimann, S Adhikari…
New England Journal of Medicine, 2020•Mass Medical SocCovid-19 in Immune-Mediated Inflammatory Diseases The authors describe patients in New
York City with known immune-mediated inflammatory disease in whom Covid-19 developed
while they were receiving biologics, other immunomodulatory therapies, or both. The
incidence of hospitalization among these patients was consistent with that among patients
with Covid-19 in the general population in New York City.
York City with known immune-mediated inflammatory disease in whom Covid-19 developed
while they were receiving biologics, other immunomodulatory therapies, or both. The
incidence of hospitalization among these patients was consistent with that among patients
with Covid-19 in the general population in New York City.
Covid-19 in Immune-Mediated Inflammatory Diseases
The authors describe patients in New York City with known immune-mediated inflammatory disease in whom Covid-19 developed while they were receiving biologics, other immunomodulatory therapies, or both. The incidence of hospitalization among these patients was consistent with that among patients with Covid-19 in the general population in New York City.
The New England Journal Of Medicine